[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403-455-7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 64, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8899, "open": 0.89, "dayLow": 0.82, "dayHigh": 0.89, "regularMarketPreviousClose": 0.8899, "regularMarketOpen": 0.89, "regularMarketDayLow": 0.82, "regularMarketDayHigh": 0.89, "payoutRatio": 0.0, "forwardPE": -0.4922156, "volume": 114584, "regularMarketVolume": 114584, "averageVolume": 115940, "averageVolume10days": 116760, "averageDailyVolume10Day": 116760, "bid": 0.8069, "ask": 0.8505, "bidSize": 1, "askSize": 1, "marketCap": 4338861, "fiftyTwoWeekLow": 0.661, "fiftyTwoWeekHigh": 2.98, "fiftyDayAverage": 0.86056, "twoHundredDayAverage": 1.01462, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2130934, "profitMargins": 0.0, "floatShares": 3680963, "sharesOutstanding": 5212220, "sharesShort": 59656, "sharesShortPriorMonth": 27458, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0117999995, "heldPercentInsiders": 0.02632, "heldPercentInstitutions": 0.04678, "shortRatio": 0.28, "shortPercentOfFloat": 0.012200001, "impliedSharesOutstanding": 5278420, "bookValue": 0.536, "priceToBook": 1.5335821, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -1880849, "trailingEps": -0.1, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.847, "52WeekChange": -0.42517483, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 0.822, "targetHighPrice": 14.49309, "targetLowPrice": 14.49309, "targetMeanPrice": 14.49309, "targetMedianPrice": 14.49309, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1063477, "totalCashPerShare": 0.281, "ebitda": -2516063, "totalDebt": 80473, "quickRatio": 1.51, "currentRatio": 1.777, "debtToEquity": 3.963, "returnOnAssets": -0.42154998, "returnOnEquity": -0.79440004, "freeCashflow": -2797770, "operatingCashflow": -3075508, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "postMarketTime": 1755300683, "regularMarketTime": 1755288000, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -7.630071, "regularMarketPrice": 0.822, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": 0.109485, "postMarketPrice": 0.8229, "postMarketChange": 0.000899971, "regularMarketChange": -0.0679, "regularMarketDayRange": "0.82 - 0.89", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 115940, "fiftyTwoWeekLowChange": 0.16100001, "fiftyTwoWeekLowChangePercent": 0.24357036, "fiftyTwoWeekRange": "0.661 - 2.98", "fiftyTwoWeekHighChange": -2.158, "fiftyTwoWeekHighChangePercent": -0.7241611, "fiftyTwoWeekChangePercent": -42.517483, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.1, "epsForward": -1.67, "epsCurrentYear": -1.574, "priceEpsCurrentYear": -0.52223635, "fiftyDayAverageChange": -0.038559973, "fiftyDayAverageChangePercent": -0.044808, "twoHundredDayAverageChange": -0.19261992, "twoHundredDayAverageChangePercent": -0.1898444, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "marketState": "CLOSED", "hasPrePostMarketData": true, "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]